SCIENTURE HOLDINGS INC (SCNX)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
$3.10-9.36%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
QuarterlyIQ Insights · SCNX
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(-25.0) + peer(0.2*-18.3) + term(0.0) → -12.4% (capped ±15.0)
in 6 days
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On October 13, 2026, Scienture Holdings, Inc. issued a press release announcing certain preliminary financial results for the quarter ending September 30, 2026, and other recent operational highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deem…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On August 14, 2026, Scienture Holdings, Inc. issued a press release announcing its financial results for the quarter ending June 30, 2026, and other recent operational highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purpose…
Results of Operations and Financial Condition. On May 18, 2026, Scienture Holdings, Inc. issued a press release announcing its financial results for the quarter ending March 31, 2026, and other recent operational highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes…
of this Current Report on form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing…
of this Current Report on form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing…
by reference. The information contained in this Current Report (and included as exhibits hereto) shall not be deemed “ filed ” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. TRxADE is making reference to non-GAAP financial information in both the press…
by reference. The information contained in this Current Report (and included as exhibits hereto) shall not be deemed “ filed ” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. TRxADE is making reference to non-GAAP financial information in both the press…
by reference. The information contained in this Current Report (and included as exhibits hereto) shall not be deemed “ filed ” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. TRxADE is making reference to non-GAAP financial information in both the press…
Results of Operations and Financial Condition. On May 9, 2022, TRxADE HEALTH, INC., (“TRxADE” or the “ Company ”) issued a press release announcing it will hold a conference call and webcast at 5:00 p.m. Eastern time regarding its financial results for the three months ended March 31, 2022. A copy of the press release, which includes information on the conference call and webcast and a summary of such financial results is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein b…
Results of Operations and Financial Condition. On March 28, 2022, TRxADE HEALTH, INC., (“ Trxade ” or the “ Company ”) issued a press release announcing it will hold a conference call and webcast at 5:00 p.m. Eastern time regarding its financial results for the three months and full year ended December 31, 2021. A copy of the press release, which includes information on the conference call and webcast and a summary of such financial results is furnished as Exhibit 99.1 to this Form 8-K and is…
Results of Operations and Financial Condition. On October 25, 2021, TRxADE HEALTH, INC., (“ Trxade ” or the “ Company ”) issued a press release announcing and will hold a conference call and webcast at 5:00 p.m. Eastern time regarding, its financial results for the three and nine months ended September 30, 2021. A copy of the press release, which includes information on the conference call and webcast and a summary of such financial results is attached as Exhibit 99.1 to this Form 8-K and is…
Results of Operations and Financial Condition. On July 26, 2021, TRxADE HEALTH, INC., formerly Trxade Group, Inc. (“ Trxade ” or the “ Company ”) issued a press release and will hold a conference call and webcast regarding its financial results for the three and six months ended June 30, 2021. A copy of the press release, which includes information on the conference call and webcast and a summary of such financial results is furnished as Exhibit 99.1 to this Form 8-K. The information containe…
Results of Operations and Financial Condition. On April 26, 2021, Trxade Group, Inc. (“ Trxade ” or the “ Company ”) issued a press release and will hold a conference call and webcast regarding its financial results for the three months ended March 31, 2021. A copy of the press release, which includes information on the conference call and webcast and a summary of such financial results is furnished as Exhibit 99.1 to this Form 8-K. The information contained in this Current Report (and includ…
Results of Operations and Financial Condition. On March 29, 2021, Trxade Group, Inc. (“ Trxade ” or the “ Company ”) issued a press release and will hold a conference call and webcast regarding its financial results for the three months and year ended December 31, 2020. A copy of the press release, which includes information on the conference call and webcast and a summary of such financial results is furnished as Exhibit 99.1 to this Form 8-K. Additionally, a copy of a presentation that will…